Isralowitz David L MD - Clifton, New Jersey 07012

Isralowitz David L MD is categorized under Doctors in Clifton, NJ .

Business Name: Isralowitz David L MD
Contact Person: David Isralowitz
Address: 6 Brighton Road, Clifton, New Jersey 07012
Phone Number: (973) 777-7911
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Lewko Michael MD - Clifton, NJ 07012
Torres Catherine P MD - Clifton, NJ 07012
Rosenberg Gene MD - Clifton, NJ 07012
Pagulayan Lorelane B MD - Clifton, NJ 07012
Pinzon Amabelle MD - Clifton, NJ 07012
Chong Raymond E MD - Clifton, NJ 07012
Mathur Mayank MD - Clifton, NJ 07012
Neurology Group-North Jersey - Clifton, NJ 07012
Ovsjanikovska Natalija MD - Clifton, NJ 07012
Jose Ibarbia, MD - Clifton, NJ 07012
Larry Rubin, MD - Clifton, NJ 07012
Boris Reydel, MD - Clifton, NJ 07012
Ian Foxall, MD - Clifton, NJ 07012
Brian Schactman, MD - Clifton, NJ 07012
Robert Lintz, MD - Clifton, NJ 07012
Cornelio Porras, MD - Clifton, NJ 07012
Mehta Sidhartha H MD - Clifton, NJ 07012
Ibarbia Jose D MD - Clifton, NJ 07012
O'Brien Joseph P MD - Clifton, NJ 07012
New Jersey Nurology - Clifton, NJ 07012

The company Isralowitz David L MD provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for Isralowitz David L MD, and the business now earns $500.000 to $999.999 per annum.

Isralowitz David L MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Isralowitz David L MD, please call David Isralowitz with the phone number (973) 777-7911 or visit its single location at 6 Brighton Road in Clifton, New Jersey 07012.

The location of the single location can also be found using the coordinates 40.858213,-74.156523. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.